Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Small Cell Lung Cancer Limited Stage × anlotinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Advanced Solid Tumors 2 Advanced Cancer 2 Small Cell Lung Cancer Limited Stage 1 Sarcoma 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Neoplasms 1 Cholangiocarcinoma 1 Brain Neoplasms 1 Advanced Cervical Cancer 1

Interventions

anlotinib 1 Chemoradiotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04882033 2021-05-11

Concurrent Chemoradiotherapy Combination With Anlotinib for Limited-stage Small Cell Lung Cancer

Tianjin Medical University Cancer Institute and Hospital

Phase 1 Unknown

Small Cell Lung Cancer Limited Stage

Data powered by HemOnc (CC BY 4.0) Colophon ⚡